Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - sumatriptansuccinat - filmovertrukne tabletter - 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - sumatriptansuccinat - filmovertrukne tabletter - 50 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

mylan pharmaceuticals limited - febuxostat - hyperuricemia; arthritis, gouty; gout - antigout præparater - febuxostat mylan er indiceret til forebyggelse og behandling af hyperurikæmi hos voksne patienter, der gennemgår kemoterapi for hæmatologiske maligniteter ved mellemliggende risici for tumor lysis syndrome (tls). febuxostat mylan er indiceret til behandling af kronisk hyperuricaemia i forhold, hvor urat deposition har allerede fundet sted (herunder en historie, eller tilstedeværelsen af, tophus og/eller arthritis urica). febuxostat mylan er indiceret hos voksne.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - febuxostathemihydrat - filmovertrukne tabletter - 120 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - febuxostathemihydrat - filmovertrukne tabletter - 80 mg

Den Europæiske Union - dansk - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cystisk fibrose - andet respirationssystem produkter - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

gilead sciences ireland uc, galapagos nv - filgotinib maleate - arthritis, reumatoid - immunosuppressiva - rheumatoid arthritisjyseleca is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). jyseleca may be used as monotherapy or in combination with methotrexate (mtx). ulcerative colitisjyseleca is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

allergan pharmaceuticals international limited - eluxadoline - irritable bowel syndrome; diarrhea - antidiarrémidler, tarm antiinflammatorisk / antiinfective agenter - truberzi er indiceret hos voksne til behandling af irritabel tarmsyndrom med diarré (ibs d).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

jubilant pharmaceuticals nv - azithromycindihydrat - filmovertrukne tabletter - 250 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - esomeprazolmagnesiumdihydrat - enterotabletter - 20 mg